| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/31/2011 | CA2172282C Chiral surfactants and methods for their use in chiral separations |
| 05/27/2011 | CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
| 05/26/2011 | WO2011063272A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 05/26/2011 | WO2011063233A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 05/26/2011 | WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same |
| 05/26/2011 | WO2011062260A1 Porous network complex, network complex encapsulating guest molecule, and method for separating guest molecule |
| 05/26/2011 | WO2011062194A1 Aminopyridine derivative |
| 05/26/2011 | WO2011061751A1 BICYCLIC COMPOUNDS AS α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| 05/26/2011 | WO2011061611A1 Process for the preparation of form b of lenalidomide |
| 05/26/2011 | WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 05/26/2011 | WO2011061318A1 Heterocylic compounds as antagonists of the orexin receptors |
| 05/26/2011 | WO2011061214A1 Novel heterocyclic acrylamides and their use as pharmaceuticals |
| 05/26/2011 | WO2011061168A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| 05/26/2011 | WO2011061139A1 Substituted pyrrolidine-2-carboxamides |
| 05/26/2011 | WO2011061080A1 Method for producing dabigatran etexilate |
| 05/26/2011 | WO2011042797A4 Pyrazole derivatives as modulators of calcium release -activated calcium channel |
| 05/26/2011 | WO2010148314A3 Preparation of esomeprazole and its pharmaceutically acceptable salts |
| 05/26/2011 | WO2010084507A3 Process for the preparation of n-methyl-2-[3-(1-methyl-4-piperidyl)-1h-indol-5-yl]-ethanesulfonamide and its acid addition salts |
| 05/26/2011 | WO2009122421A3 Improved process for eprosartan intermediate |
| 05/26/2011 | US20110124871 Arthropodicidal anthranilamides |
| 05/26/2011 | US20110124870 Novel mycobacterial inhibitors |
| 05/26/2011 | US20110124867 Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity |
| 05/26/2011 | US20110124857 Arthropodicidal anthranilamides |
| 05/26/2011 | US20110124808 Polymeric compound containing metal complex residue and element comprising same |
| 05/26/2011 | US20110124684 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase |
| 05/26/2011 | US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
| 05/26/2011 | US20110124669 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124666 3,4-dihydropyrimidine trpa1 antagonists |
| 05/26/2011 | US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/26/2011 | US20110124662 Substituted Carbamate Derivatives as Modulators of Corticotropin-Releasing Factor Receptor Activity |
| 05/26/2011 | US20110124661 Oxazolobenzimidazole derivatives |
| 05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124652 Chemical Compounds and Uses |
| 05/26/2011 | US20110124649 Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders |
| 05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
| 05/26/2011 | US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy |
| 05/26/2011 | US20110124632 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
| 05/26/2011 | US20110124628 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/26/2011 | US20110124626 Benzazepine derivatives and their use as histamine h3 antagonists |
| 05/26/2011 | US20110124625 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110123555 Preparation and utility of ccr5 inhibitors |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | CA2780715A1 Method for producing dabigatran etexilate |
| 05/26/2011 | CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | CA2778867A1 Substituted pyrrolidine-2-carboxamides |
| 05/26/2011 | CA2776849A1 Novel heterocyclic acrylamides and their use as pharmaceuticals |
| 05/26/2011 | CA2773409A1 Bicyclic compounds as .alpha.4.beta.2 nicotinic acetylcholine receptor ligands |
| 05/25/2011 | EP2325279A2 Electroluminescent iridium compounds |
| 05/25/2011 | EP2325189A2 Chemical coupling process with a phenyl boronic acid derivative |
| 05/25/2011 | EP2325182A1 Bicyclic compounds and use as antidiabetics |
| 05/25/2011 | EP2325181A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 05/25/2011 | EP2325180A1 Chiral CIS-imidazolines |
| 05/25/2011 | EP2325175A1 2,4-diaminopyrimidine compound |
| 05/25/2011 | EP2325174A1 Sigma receptor inhibitors |
| 05/25/2011 | EP2324843A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324014A2 Silent desensitizers of neuronal nachr and methods of use thereof |
| 05/25/2011 | EP2324012A1 New compounds |
| 05/25/2011 | EP2324011A1 Fungicidal n-(2-pyridylpropyl)carboxamide derivatives and their oxa, aza and thia analogues |
| 05/25/2011 | EP2324010A1 Insecticidal phenyl- or pyridyl-piperidine compounds |
| 05/25/2011 | EP2324009A1 Process for preparing certain cinnamide compounds |
| 05/25/2011 | EP2324008A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 05/25/2011 | EP2324007A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 05/25/2011 | EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/25/2011 | EP2323992A1 5-alkynyl-pyrimidines |
| 05/25/2011 | EP2323988A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 05/25/2011 | EP2323986A2 Hetoerocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors |
| 05/25/2011 | EP2323980A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 05/25/2011 | EP2323978A1 Amide compound |
| 05/25/2011 | EP2323737A2 Triazole compounds that modulate hsp90 activity |
| 05/25/2011 | EP2323661A1 A3 adenosine receptor allosteric modulators |
| 05/25/2011 | EP2212297B1 Inhibitors of protein kinases |
| 05/25/2011 | EP2158197B1 Method for the preparation of high purity almotriptan |
| 05/25/2011 | EP2125748B1 Acylaminopyrazoles as fgfr inhibitors |
| 05/25/2011 | EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 05/25/2011 | EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 05/25/2011 | EP1534296B1 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1980674B Phthalazine derivatives as parp inhibitors |
| 05/25/2011 | CN1863770B Cyclic amine BASE-1 inhibitors having a heterocyclic substituent |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102076679A Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/25/2011 | CN102076673A Novel imino derivative, process for production of same, and pesticide comprising same |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102076669A Substituted n-oxide pyrazine derivatives |
| 05/25/2011 | CN102076666A Aminopyridine derivatives |
| 05/25/2011 | CN102076665A Organic compounds |
| 05/25/2011 | CN102070614A Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 05/25/2011 | CN102070613A Analogue of (Z) type bivalent nitenpyram and preparation method thereof |
| 05/25/2011 | CN102070612A Method for preparing hydroxyl fasudil compounds |
| 05/25/2011 | CN102070611A Preparation method of amlodipine intermediate |
| 05/25/2011 | CN102070610A 1,4-dihydropyridine ring-containing cis-neonicotinoid compounds and preparation thereof |
| 05/25/2011 | CN102070609A Cis nitenpyram analog containing 1,4-dihydropyridine ring and preparation method thereof |